Search for a doctor

Bill Cliby, M.D.

  1. Gynecologic Oncologist
  2. Gynecologist
Request an Appointment

Publications

  1. Cliby WA, Halfdanarson TR, Kibbi N, Owen JL, Worley B, Alam M, Extramammary Paget's Disease Guideline Study Group. Recommended Guidelines for Screening for Underlying Malignancy in Extramammary Paget's Disease Based on Anatomic Subtype. J Am Acad Dermatol. 2024 Oct 12 [Epub ahead of print]
    View PubMed
  2. Caruso G, Langstraat CL, Kumar A, McGree ME, Fought AJ, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby WA. Textbook oncologic outcome is an easy-to-use composite quality measure that is strongly associated with survival in advanced-stage ovarian cancer. Gynecol Oncol. 2024 Oct 3; 191:86-94 Epub 2024 Oct 03
    View PubMed
  3. Fumagalli D, Sonik R, De Vitis LA, Rossi V, Bazzurini L, McGree ME, Fought AJ, Mariani A, Cliby WA, Kumar A. Evaluating nutrition in advanced ovarian cancer: which biomarker works best? Gynecol Oncol. 2024 Sep; 188:97-102 Epub 2024 June 28
    View PubMed
  4. Ostby SA, Narasimhulu D, Ochs Kinney MA, Cliby W, Langstraat C, Bakkum-Gamez JN, Ishitani K, Lemens M, Martin P, Borah B, Moriarty J, Glaser G, Kumar A, Arendt KW, Dowdy SC. Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial. Gynecol Oncol. 2024 Aug 7; 190:11-17 Epub 2024 Aug 07
    View PubMed
  5. Mohammad A, Ainio C, Narasimhulu DM, McGree M, Weaver AL, Kumar A, Garbi A, Mariani A, Aletti G, Multinu F, Langstraat C, Cliby W. Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes. Int J Gynecol Cancer. 2024 Aug 5; 34 (8):1240-1245 Epub 2024 Aug 05
    View PubMed
  6. Kailasam A, Jatoi A, Reynolds E, Cliby W, Langstraat C. Understanding the patient experience in nonsurgical management of endometrial cancer and complex atypical hyperplasia due to obesity: A qualitative analysis. Gynecol Oncol Rep. 2024 Aug; 54:101425 Epub 2024 May 27
    View PubMed
  7. Hoffman M, Dunsmore V, Cliby W, Chi D, Wheeler S, Clarke-Pearson D. Surgical training of gynecologic oncology fellows: Long-term trends and implications for future education. Gynecol Oncol. 2024 May; 184:254-258 Epub 2024 May 01
    View PubMed
  8. Bruce KH, Moriarty JP, Borah BJ, Dholakia R, Lohman ME, Brewer JD, Vidal NY, Bakkum-Gamez JN, Cliby WA. Cost-effectiveness analysis of margin-controlled surgery for vulvar Paget's disease. Gynecol Oncol Rep. 2024 Apr; 52:101339 Epub 2024 Feb 22
    View PubMed
  9. Grant P, Quinn M, O'Neill H, Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching PA, Lambrechts D, Garcia MJ, Rodriguez-Antona C, Goodman MT, Modugno F, Moysich KB, Karlan BY, Lester J, Kjaer SK, Jensen A, Hogdall E, Goode EL, Cliby WA, Kumar A, Wang C, Cunningham JM, Winham SJ, Monteiro AN, Schildkraut JM, Cramer DW, Terry KL, Titus L, Bjorge L, Thomsen LCV, Pejovic T, Hogdall CK, McNeish IA, May T, Huntsman DG, Pfisterer J, Canzler U, Park-Simon TW, Schroder W, Belau A, Hanker L, Harter P, Sehouli J, Kimmig R, de Gregorio N, Schmalfeldt B, Baumann K, Hilpert F, Burges A, Winterhoff B, Schurmann P, Speith LM, Hillemanns P, Berchuck A, Johnatty SE, Ramus SJ, Chenevix-Trench G, Pharoah PDP, Dork T, Heitz F, AOCS Group//OPAL Study Group. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. NPJ Genom Med. 2024 Mar 5; 9 (1):19 Epub 2024 Mar 05
    View PubMed
  10. Caruso G, Bruni S, Lapresa M, De Vitis LA, Parma G, Minicucci V, Betella I, Schivardi G, Peccatori F, Lazzari R, Cliby W, Aletti GD, Zanagnolo V, Maggioni A, Colombo N, Multinu F. Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review. Int J Gynecol Cancer. 2024 Jan 05; 34(1):47-57.
    View PubMed
  11. Schivardi G, Casarin J, Habermann EB, Bews KA, Langstraat CL, Cliby W, Cucinella G, De Vitis LA, Ramirez PT, Aletti GD, Mariani A, Multinu F. Practice patterns and complications of hysterectomy for invasive cervical cancer after the Laparoscopic Approach to Cervical Cancer trial. Am J Obstet Gynecol. 2024 Jan; 230(1):69.e1-69.e10. Epub 2023 Sep 09.
    View PubMed
  12. Chauhan S, Langstraat CL, Fought AJ, McGree ME, Cliby WA, Kumar A. Relationship between frailty and nutrition: Refining predictors of mortality after primary cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2024 Jan; 180:126-131. Epub 2023 Dec 12.
    View PubMed
  13. Bruce KH, Kilts TP, Lohman ME, Vidal NY, Fought AJ, McGree ME, Keeney GL, Baum CL, Brewer JD, Bakkum-Gamez JN, Cliby WA. Mohs surgery for female genital Paget's disease: a prospective observational trial. Am J Obstet Gynecol. 2023 Dec; 229(6):660.e1-660.e8. Epub 2023 Aug 24.
    View PubMed
  14. Kailasam A, Cucinella G, Fought AJ, Cliby W, Mariani A, Glaser G, Langstraat C. Nonsurgical management of early-stage endometrial cancer due to obesity: a survey of the practice patterns of current Society of Gynecologic Oncology members. Gynecol Oncol Rep. 2023 Dec; 50:101280 Epub 2023 Oct 04
    View PubMed
  15. Caruso G, Coleman RL, Aletti G, Multinu F, Botticelli A, Palaia I, Cliby W, Colombo N. Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon? Int J Gynecol Cancer. 2023 Sep 4; 33 (9):1448-1457 Epub 2023 Sept 04
    View PubMed
  16. Polen-De C, Giri S, Fadadu P, Weaver A, Mcgree ME, Moynagh M, Takahashi N, Jatoi A, Lebrasseur NK, Cliby W, Williams G, Kumar A. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer. J Natl Cancer Inst Monogr. 2023 May 04; 2023(61):43-48.
    View PubMed
  17. Mohammad A, Ainio C, Narasimhulu DM, McGree M, Weaver AL, Kumar A, Garbi A, Mariani A, Aletti G, Multinu F, Langstraat C, Cliby W. Comparison of the Contracted Accordion, Expanded Accordion, and Clavien-Dindo complication grading scales after ovarian cancer cytoreduction. Int J Gynecol Cancer. 2023 May 01; 33(5):727-733.
    View PubMed
  18. Straubhar AM, Zhou Q, Iasonos A, Clarke-Pearson DL, Cliby WA, Hoffman MS, Chi DS. Cross-sectional survey of surgical practices among gynecologic oncologists in the United States. Gynecol Oncol. 2023 May; 172:36-40 Epub 2023 Mar 16
    View PubMed
  19. Narasimhulu DM, Fagotti A, Scambia G, Weaver AL, McGree M, Quagliozzi L, Langstraat C, Kumar A, Cliby W. Validation of a risk-based algorithm to reduce poor operative outcomes after complex surgery for ovarian cancer. Int J Gynecol Cancer. 2023 Jan 3; 33 (1):83-88 Epub 2023 Jan 03
    View PubMed
  20. Warring SK, Narasimhulu DM, Kumar A, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Next steps toward reducing surgical morbidity after complex cytoreductive surgery in fit surgical patients. Journal of Gynecologic Surgery. 2023; 39 (3):123-9
  21. Kumar A, Wang C, Sheedy SP, McCauley BM, Winham SJ, Ramus SJ, Anglesio MS, Kim B, Torres D, Keeney GL, Cliby WA, Goode EL. Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. Gynecol Oncol. 2022 Sep; 166 (3):508-514 Epub 2022 Aug 02
    View PubMed
  22. Polen-De C, Fadadu P, Weaver AL, Moynagh M, Takahashi N, Jatoi A, LeBrasseur NK, McGree M, Cliby W, Kumar A. Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer. Int J Gynecol Cancer. 2022 Jun 9 Epub 2022 June 09
    View PubMed
  23. Altmann J, Chekerov R, Fotopoulou C, Muallem MZ, du Bois A, Cliby W, Dowdy S, Podratz K, Lichtenegger W, Camara O, Tunn R, Cibula D, Kuemmel S, Scambia G, Vergote I, Chiantera V, Pietzner K, Inci MG, Chopra S, Biebl M, Neymeyer J, Blohmer JU, Sehouli J. Ten years of live surgical broadcast at Charite-MAYO conferences (2010-2019): a systematic evaluation of the surgical outcome. Int J Gynecol Cancer. 2022 Jun 6; 32 (6):746-752 Epub 2022 June 06
    View PubMed
  24. Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM Jr, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol. 2022 Apr 1; 8 (4):618-628
    View PubMed
  25. Uccella S, Garzon S, Bosco M, Porcari I, Lanzo G, Lagana AS, Chiantera V, Cliby WA, Mariani A, Franchi M, Zorzato PC. Cervical versus Utero-Ovarian Ligament Injection of the Tracer for the Pelvic Sentinel Lymph Node Mapping in Gynecologic Oncology: A Prospective Observational Study. Gynecol Obstet Invest. 2022; 87 (3-4):242-247 Epub 2022 May 18
    View PubMed
  26. Gill SE, Garzon S, Multinu F, Hokenstad AN, Casarin J, Cappuccio S, McGree ME, Weaver AL, Cliby WA, Keeney GL, Mariani A. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences. Int J Gynecol Cancer. 2021 Dec; 31(12):1541-1548. Epub 2021 Oct 27.
    View PubMed
  27. Thannickal A, Maddy B, DeWitt M, Cliby W, Dow M. Dysfunctional labor and hemoperitoneum secondary to an incidentally discovered dysgerminoma: a case report. BMC Pregnancy Childbirth. 2021 Sep 7; 21 (1):611 Epub 2021 Sept 07
    View PubMed
  28. Narasimhulu DM, Thannickal A, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy. Gynecol Oncol. 2021 Mar; 160 (3):681-687 Epub 2020 Dec 31
    View PubMed
  29. Crooks TA, Madison JD, Walsh DM, Herbert WG, Jeraldo PR, Chia N, Cliby WA, Kaufmann SH, Walther-Antonio MRS. Porphyromonas somerae Invasion of Endometrial Cancer Cells. Front Microbiol. 2021; 12:674835 Epub 2021 July 23
    View PubMed
  30. Bosquet JG, Zhang Q, Cliby WA, Bakkum-Gamez JN, Cen L, Dowdy SC, Sherman ME, Weroha SJ, Clayton AC, Kipp BR, Halling KC, Couch FJ, Podratz KC. Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options. PLoS One. 2021; 16 (1):e0245664 Epub 2021 Jan 27
    View PubMed
  31. Fadadu PP, Polen-De CL, McGree ME, Weaver AL, Moynagh MR, Takahashi N, Langstraat CL, Cliby WA, Kumar A. Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation. Gynecol Oncol. 2021 Jan; 160(1):40-44. Epub 2020 Oct 24.
    View PubMed
  32. Yang J, Mead-Harvey C, Polen-De C, Magtibay P, Butler K, Cliby W, Langstraat C, Dinh T, Chen L, Magrina J. Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: Our surgical pathology interrogation. Gynecol Oncol. 2020 Nov; 159 (2):373-380 Epub 2020 Sept 03
    View PubMed
  33. Hoffman MS, Chi DS, Clarke-Pearson DL, Cliby W, Creasman W, Underwood PB Jr. Surgical training in gynecologic oncology: Past, present, future. Gynecol Oncol. 2020 Jul; 158 (1):188-193 Epub 2020 May 23
    View PubMed
  34. Narasimhulu DM, Kumar A, Weaver AL, Langstraat CL, Cliby WA. Less guessing, more evidence in identifying patients least fit for cytoreductive surgery in advanced ovarian cancer: A triage algorithm to individualize surgical management. Gynecol Oncol. 2020 Jun; 157 (3):572-577 Epub 2020 Apr 01
    View PubMed
  35. Kilts TP, Long B, Glasgow AE, Bakkum-Gamez JN, Habermann EB, Cliby WA. Invasive vulvar extramammary Paget's disease in the United States. Gynecol Oncol. 2020 Jun; 157 (3):649-655 Epub 2020 Apr 05
    View PubMed
  36. Kumar A, Cliby WA. Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery. Clin Obstet Gynecol. 2020 Mar; 63 (1):74-79
    View PubMed
  37. Casarin J, Song C, Multinu F, Cappuccio S, Liu E, Butler KA, Glaser GE, Cliby WA, Langstraat CL, Ghezzi F, Fu AZ, Mariani A. Implementing robotic surgery for uterine cancer in the United States: Better outcomes without increased costs. Gynecol Oncol. 2020 Feb; 156 (2):451-458 Epub 2019 Nov 25
    View PubMed
  38. Narasimhulu DM, Bews KA, Hanson KT, Chang YH, Dowdy SC, Cliby WA. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2020 Feb; 156 (2):278-283 Epub 2019 Nov 27
    View PubMed
  39. Schlappe BA, Weaver AL, McGree ME, Ducie J, Zahl Eriksson AG, Dowdy SC, Cliby WA, Glaser GE, Abu-Rustum NR, Mariani A, Leitao MM Jr. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. Gynecol Oncol. 2020 Jan; 156 (1):62-69 Epub 2019 Nov 24
    View PubMed
  40. Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE, Grassi T, Keeney GL, Weaver AL, Abu-Rustum NR, Leitao MM Jr, Mariani A. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm. Gynecol Oncol. 2019 Nov; 155 (2):177-185 Epub 2019 Oct 08
    View PubMed
  41. Narasimhulu DM, Kumar A, Weaver AL, McGree ME, Langstraat CL, Cliby WA. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2019 Oct; 155(1):58-62. Epub 2019 Aug 08.
    View PubMed
  42. Kilts TP, Glaser GE, Langstraat CL, Kumar A, Weaver AL, Mc Gree ME, Gostout BS, Podratz KC, Dowdy SC, Cliby WA, Mariani A, Bakkum-Gamez JN. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer. Gynecol Oncol. 2019 Oct; 155 (1):21-26 Epub 2019 Aug 10
    View PubMed
  43. Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, Staub JK, Cliby WA, Weroha SJ, Kalli KR, Hartmann LC, Kaufmann SH, Goode EL, Shridhar V. Genes associated with bowel metastases in ovarian cancer. Gynecol Oncol. 2019 Sep; 154 (3):495-504 Epub 2019 June 14
    View PubMed
  44. Dumas K, Wilbur M, Dillon J, Cliby W, Langstraat C, Fader AN, Xing D, Stone RL. Paraneoplastic nodular regenerative hyperplasia of the liver associated with placental site trophoblastic tumor. Gynecol Oncol Rep. 2019 Aug; 29:16-19 Epub 2019 May 18
    View PubMed
  45. Mert I, Cliby WA, Bews KA, Habermann EB, Dowdy SC. Evidence-based wound classification for vulvar surgery: Implications for risk adjustment. Gynecol Oncol. 2019 Aug; 154 (2):280-282 Epub 2019 June 25
    View PubMed
  46. Kumar A, Sheedy S, Kim B, Suidan R, Sarasohn DM, Nikolovski I, Lakhman Y, McGree ME, Weaver AL, Chi D, Cliby WA. Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease. Gynecol Oncol. 2019 Jul; 154(1):72-76. Epub 2019 Apr 16.
    View PubMed
  47. Multinu F, Casarin J, Cappuccio S, Keeney GL, Glaser GE, Cliby WA, Weaver AL, McGree ME, Angioni S, Faa G, Leitao MM Jr, Abu-Rustum NR, Mariani A. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer. Gynecol Oncol. 2019 Jul; 154(1):60-64. Epub 2019 May 22.
    View PubMed
  48. Mert I, Kumar A, Torres D, Huang Y, McGree ME, Weaver AL, Cliby WA. Should mucosal bowel invasion in ovarian cancer be assigned to FIGO stage IV disease? Gynecol Oncol. 2019 May; 153(2):238-241. Epub 2019 Mar 02.
    View PubMed
  49. Kumar A, Wallace SA, Cliby WA, Glaser GE, Mariani A, Leitao MM, Frumovitz M, Langstraat CL. Impact of Sentinel Node Approach in Gynecologic Cancer on Training Needs. J Minim Invasive Gynecol. 2019 May - Jun; 26 (4):727-732 Epub 2018 Aug 20
    View PubMed
  50. Yao T, DeJong SR, McGree ME, Weaver AL, Cliby WA, Kumar A. Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery. Gynecol Oncol. 2019 Apr; 153(1):68-73. Epub 2019 Jan 03.
    View PubMed
  51. Zhang Q, Wang C, Cliby WA. Cancer-associated stroma significantly contributes to the mesenchymal subtype signature of serous ovarian cancer. Gynecol Oncol. 2019 Feb; 152 (2):368-374 Epub 2018 Nov 15
    View PubMed
  52. Wagner BE, Langstraat CL, McGree ME, Weaver AL, Sarangi S, Mokri B, Dowdy SC, Cliby WA, Kumar A, Bakkum-Gamez JN. Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer. Gynecol Oncol. 2019 Feb; 152(2):286-292. Epub 2018 Nov 22.
    View PubMed
  53. Torres D, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Wang C, Langstraat CL, Cliby WA. Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2019 Feb; 152(2):223-227. Epub 2018 Nov 28.
    View PubMed
  54. Casarin J, Multinu F, Abu-Rustum N, Cibula D, Cliby WA, Ghezzi F, Leitao M, Konishi I, Nam JH, Querleu D, Soliman PT, Yost KJ, Weaver AL, Mariani A, Glaser GE. Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists. Int J Gynecol Cancer. 2019 Jan; 29 (1):60-67
    View PubMed
  55. Tortorella L, Casarin J, Mara KC, Weaver AL, Multinu F, Glaser GE, Cliby WA, Scambia G, Mariani A, Kumar A. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol. 2019 Jan; 152 (1):151-156 Epub 2018 Nov 08
    View PubMed
  56. Kumar S, Oien DB, Khurana A, Cliby W, Hartmann L, Chien J, Shridhar V. Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer. Front Oncol. 2019; 9:986 Epub 2019 Oct 01
    View PubMed
  57. Dowdy SC, Cliby WA, Famuyide AO. Quality indicators in gynecologic oncology. Gynecol Oncol. 2018 Nov; 151 (2):366-373 Epub 2018 Sept 13
    View PubMed
  58. Schlappe BA, Weaver AL, Ducie JA, Eriksson AGZ, Dowdy SC, Cliby WA, Glaser GE, Soslow RA, Alektiar KM, Makker V, Abu-Rustum NR, Mariani A, Leitao MM Jr. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. Gynecol Oncol. 2018 Nov; 151 (2):235-242 Epub 2018 Aug 31
    View PubMed
  59. Zhang Q, Hou X, Evans BJ, VanBlaricom JL, Weroha SJ, Cliby WA. LY2157299 Monohydrate, a TGF-ßR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer. Cancers (Basel). 2018 Aug 07; 10(8).
    View PubMed
  60. Torres D, Wang C, Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Konecny GE, Goode EL, Cliby WA. Factors that influence survival in high-grade serous ovarian cancer: A complex relationship between molecular subtype, disease dissemination, and operability. Gynecol Oncol. 2018 Aug; 150(2):227-232. Epub 2018 Jun 18.
    View PubMed
  61. Schmitt AR, Long BJ, Weaver AL, McGree ME, Bakkum-Gamez JN, Brewer JD, Cliby WA. Evidence-Based Screening Recommendations for Occult Cancers in the Setting of Newly Diagnosed Extramammary Paget Disease. Mayo Clin Proc. 2018 Jul; 93(7):877-883. Epub 2018 May 24.
    View PubMed
  62. Wallace SK, Halverson JW, Jankowski CJ, DeJong SR, Weaver AL, Weinhold MR, Borah BJ, Moriarty JP, Cliby WA, Kor DJ, Higgins AA, Otto HA, Dowdy SC, Bakkum-Gamez JN. Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy. Obstet Gynecol. 2018 May; 131 (5):891-898
    View PubMed
  63. Tortorella L, Langstraat CL, Weaver AL, McGree ME, Bakkum-Gamez JN, Dowdy SC, Cliby WA, Keeney GL, Sherman ME, Weroha SJ, Mariani A, Podratz KC. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy. Gynecol Oncol. 2018 May; 149(2):291-296. Epub 2018 Mar 14.
    View PubMed
  64. Casarin J, Multinu F, Ubl DS, Dowdy SC, Cliby WA, Glaser GE, Butler KA, Ghezzi F, Habermann EB, Mariani A. Adoption of Minimally Invasive Surgery and Decrease in Surgical Morbidity for Endometrial Cancer Treatment in the United States. Obstet Gynecol. 2018 Feb; 131 (2):304-311
    View PubMed
  65. Mert I, Kumar A, Sheedy SP, Weaver AL, McGree ME, Kim B, Cliby WA. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival. Gynecol Oncol. 2018 Jan; 148(1):68-73. Epub 2017 Nov 10.
    View PubMed
  66. Torres D, Kumar A, Wallace SK, Bakkum-Gamez JN, Konecny GE, Weaver AL, McGree ME, Goode EL, Cliby WA, Wang C. Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer. Gynecol Oncol. 2017 Dec; 147(3):503-508. Epub 2017 Sep 28.
    View PubMed
  67. Ducie JA, Eriksson AGZ, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Soslow RA, Keeney GL, Abu-Rustum NR, Mariani A, Leitao MM Jr. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease. Gynecol Oncol. 2017 Dec; 147(3):541-548. Epub 2017 Sep 29.
    View PubMed
  68. Kumar A, Hurtt CC, Cliby WA, Martin JR, Weaver AL, McGree ME, Langstraat CL, Bakkum-Gamez JN. Concomitant venous thromboembolism at the time of primary EOC diagnosis: Perioperative outcomes and survival analyses. Gynecol Oncol. 2017 Dec; 147(3):514-520. Epub 2017 Sep 22.
    View PubMed
  69. Rastegar-Mojarad M, Sohn S, Wang L, Shen F, Bleeker TC, Cliby WA, Liu H. Need of informatics in designing interoperable clinical registries. Int J Med Inform. 2017 Dec; 108:78-84 Epub 2017 Oct 10
    View PubMed
  70. Long B, Schmitt AR, Weaver AL, McGree M, Bakkum-Gamez JN, Brewer J, Cliby WA. A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease. Gynecol Oncol. 2017 Nov; 147 (2):358-363 Epub 2017 Sept 19
    View PubMed
  71. Gill SE, Zhang Q, Keeney GL, Cliby WA, Weroha SJ. Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR. Oncotarget. 2017 Oct 17; 8 (49):85214-85223 Epub 2017 July 27
    View PubMed
  72. Bogani G, Gostout BS, Dowdy SC, Multinu F, Casarin J, Cliby WA, Frigerio L, Kim B, Weaver AL, Glaser GE, Mariani A. Clinical Utility of Preoperative Computed Tomography in Patients With Endometrial Cancer. Int J Gynecol Cancer. 2017 Oct; 27 (8):1685-1693
    View PubMed
  73. Kumar A, Langstraat CL, DeJong SR, McGree ME, Bakkum-Gamez JN, Weaver AL, LeBrasseur NK, Cliby WA. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer. Gynecol Oncol. 2017 Oct; 147(1):104-109. Epub 2017 Jul 19.
    View PubMed
  74. Wang C, Armasu SM, Kalli KR, Maurer MJ, Heinzen EP, Keeney GL, Cliby WA, Oberg AL, Kaufmann SH, Goode EL. Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. Clin Cancer Res. 2017 Aug 1; 23 (15):4077-4085 Epub 2017 Mar 09
    View PubMed
  75. Kumar A, Torres ML, Cliby WA, Kalli KR, Bogani G, Aletti G, Nitschmann CC, Multinu F, Weaver AL, Block MS, Mariani A. Inflammatory and Nutritional Serum Markers as Predictors of Peri-operative Morbidity and Survival in Ovarian Cancer. Anticancer Res. 2017 Jul; 37 (7):3673-3677
    View PubMed
  76. Nitschmann CC, Multinu F, Bakkum-Gamez JN, Langstraat CL, Occhino JA, Weaver AL, Cliby WA, Mariani A, Dowdy SC. Vaginal vs. robotic hysterectomy for patients with endometrial cancer: A comparison of outcomes and cost of care. Gynecol Oncol. 2017 Jun; 145 (3):555-561 Epub 2017 Apr 06
    View PubMed
  77. Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE. Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study. Int J Gynecol Cancer. 2017 May; 27 (4):675-683
    View PubMed
  78. Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol. 2017 Apr; 145(1):21-26. Epub 2017 Jan 31.
    View PubMed
  79. Gill SE, McGree ME, Weaver AL, Cliby WA, Langstraat CL. Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection. Gynecol Oncol. 2017 Feb; 144 (2):266-273 Epub 2016 Dec 01
    View PubMed
  80. Kalogera E, Nitschmann CC, Dowdy SC, Cliby WA, Langstraat CL. A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies. Gynecol Oncol. 2017 Feb; 144: (2)343-347.
    View PubMed
  81. Kalogera E, Bakkum-Gamez JN, Weaver AL, Moriarty JP, Borah BJ, Langstraat CL, Jankowski CJ, Lovely JK, Cliby WA, Dowdy SC. Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use After Laparotomy for Gynecologic Malignancies. Obstet Gynecol. 2016 Nov; 128 (5):1009-1017
    View PubMed
  82. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016 Oct; 143 (1):3-15 Epub 2016 Aug 08
    View PubMed
  83. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 Oct 1; 34 (28):3460-73 Epub 2016 Aug 08
    View PubMed
  84. Trabuco EC, Moorman PG, Cliby WA. In Reply. Obstet Gynecol 2016 Sep; 128 (3):655-656
    View PubMed
  85. Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E. Outcomes and Postoperative Complications After Hysterectomies Performed for Benign Compared With Malignant Indications. Obstet Gynecol. 2016 Sep; 128 (3):467-475
    View PubMed
  86. Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016 Aug; 142 (2):311-6 Epub 2016 June 02
    View PubMed
  87. Uccella S, Morris JM, Multinu F, Cliby WA, Podratz KC, Gostout BS, Dowdy SC, Ghezzi F, Makdisi PB, Keeney GL, Link MJ, Mariani A. Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature. Gynecol Oncol. 2016 Jul; 142 (1):70-75 Epub 2016 Apr 26
    View PubMed
  88. Trabuco EC, Moorman PG, Algeciras-Schimnich A, Weaver AL, Cliby WA. Association of Ovary-Sparing Hysterectomy With Ovarian Reserve. Obstet Gynecol. 2016 May; 127 (5):819-827
    View PubMed
  89. Bogani G, Multinu F, Dowdy SC, Cliby WA, Wilson TO, Gostout BS, Weaver AL, Borah BJ, Killian JM, Bijlani A, Angioni S, Mariani A. Incorporating robotic-assisted surgery for endometrial cancer staging: Analysis of morbidity and costs. Gynecol Oncol. 2016 May; 141 (2):218-224 Epub 2016 Feb 16
    View PubMed
  90. Wallace SK, Lin JF, Cliby WA, Leiserowitz GS, Tergas AI, Bristow RE. Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study. J Natl Compr Canc Netw. 2016 May; 14 (5):539-50
    View PubMed
  91. Winterhoff B, Hamidi H, Wang C, Kalli KR, Fridley BL, Dering J, Chen HW, Cliby WA, Wang HJ, Dowdy S, Gostout BS, Keeney GL, Goode EL, Konecny GE. Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures. Gynecol Oncol. 2016 Apr; 141 (1):95-100
    View PubMed
  92. Janco JM, Kumar A, Weaver AL, McGree ME, Cliby WA. Performance of AGO score for secondary cytoreduction in a high-volume U.S. center. Gynecol Oncol. 2016 Apr; 141(1):140-7. Epub 2016 Feb 02.
    View PubMed
  93. Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, Cliby WA, Dowdy SC, Bakkum-Gamez JN, Abu-Rustum NR, Mariani A, Leitao MM Jr. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol. 2016 Mar; 140(3):394-9. Epub 2015 Dec 31.
    View PubMed
  94. Al Hilli MM, Bakkum-Gamez JN, Mariani A, Cliby WA, Mc Gree ME, Weaver AL, Dowdy SC, Podratz KC. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts. Gynecol Oncol. 2016 Feb; 140 (2):270-6 Epub 2015 Dec 01
    View PubMed
  95. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Frigerio L, Mariani A. Management of endometrial cancer: issues and controversies European Journal Of Gynaecological Oncology. 2016; 37: (1)6-12.
  96. Basal E, Ayeni T, Zhang Q, Langstraat C, Donahoe PK, Pepin D, Yin X, Leof E, Cliby W. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer. Curr Mol Med. 2016; 16(3):222-31.
    View PubMed
  97. Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME, Cliby WA. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2016 Jan; 140 (1):15-21 Epub 2015 Nov 02
    View PubMed
  98. Smits A, Lopes A, Das N, Kumar A, Cliby W, Smits E, Bekkers R, Massuger L, Galaal K. Surgical morbidity and clinical outcomes in ovarian cancer - the role of obesity. BJOG. 2015 Sep 02.
    View PubMed
  99. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of gynecologic oncology and American Society of Clinical Oncology clinical practice guideline Obstetrical and Gynecological Survey. 2016; 71: (12)717-8.
  100. Bogani G, Dowdy SC, Cliby WA, Gostout BS, Kumar S, Ghezzi F, Multinu F, Mariani A. Incisional Recurrences After Endometrial Cancer Surgery. Anticancer Res. 2015 Nov; 35: (11)6097-104.
    View PubMed
  101. Hecht ES, Scholl EH, Walker SH, Taylor AD, Cliby WA, Motsinger-Reif AA, Muddiman DC. Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples. J Proteome Res. 2015 Oct 2; 14 (10):4394-401 Epub 2015 Sept 14
    View PubMed
  102. Chang SJ, Bristow RE, Chi DS, Cliby WA. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol. 2015 Oct; 26 (4):336-42 Epub 2015 July 17
    View PubMed
  103. Dottino JA, Cliby WA, Myers ER, Bristow RE, Havrilesky LJ. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention. Gynecol Oncol. 2015 Sep; 138: (3)694-9.
    View PubMed
  104. Janco JM, Glaser G, Kim B, McGree ME, Weaver AL, Cliby WA, Dowdy SC, Bakkum-Gamez JN. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2015 Jul; 138 (1):70-7 Epub 2015 Apr 22
    View PubMed
  105. Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic. Gynecol Oncol. 2015 Apr; 137 (1):77-85 Epub 2015 Jan 22
    View PubMed
  106. Bakkum-Gamez JN, Wentzensen N, Maurer MJ, Hawthorne KM, Voss JS, Kroneman TN, Famuyide AO, Clayton AC, Halling KC, Kerr SE, Cliby WA, Dowdy SC, Kipp BR, Mariani A, Oberg AL, Podratz KC, Shridhar V, Sherman ME. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol Oncol. 2015 Apr; 137 (1):14-22 Epub 2015 Feb 10
    View PubMed
  107. Bogani G, Cliby WA, Aletti GD. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol Oncol. 2015 Apr; 137 (1):167-72 Epub 2014 Nov 20
    View PubMed
  108. Janco JMT, Gloviczki P, Friese JL, Cliby WA. Lymphatic mapping and ligation for persistent ascites after surgery for gynecologic malignancy. Obstet Gynecol. 2015 Feb; 125 (2):434-437
    View PubMed
  109. Bogani G, Liu MC, Dowdy SC, Cliby WA, Kerr SE, Kalli KR, Kipp BR, Halling KC, Campion MB, Mariani A. Detection of circulating tumor cells in high-risk endometrial cancer. Anticancer Res. 2015 Feb; 35(2):683-7.
    View PubMed
  110. Tran CW, McGree ME, Weaver AL, Martin JR, Lemens MA, Cliby WA, Dowdy SC, Bakkum-Gamez JN. Surgical site infection after primary surgery for epithelial ovarian cancer: predictors and impact on survival. Gynecol Oncol. 2015 Feb; 136(2):278-84. Epub 2014 Dec 11.
    View PubMed
  111. AlHilli M, Langstraat C, Tran C, Martin J, Weaver A, McGree M, Mariani A, Cliby W, Bakkum-Gamez J. Risk factors and indications for 30-day readmission after primary surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2015 Feb; 25(2):193-202.
    View PubMed
  112. Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, Mutch DG, Bristow RE. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival. Gynecol Oncol. 2015 Jan; 136 (1):11-7 Epub 2014 Oct 29
    View PubMed
  113. Tolcher MC, Swisher EM, Medeiros F, Lima JF, Hilderbrand JL, Donovan JL, Garcia RL, Cliby WA, Dowdy SC. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma. Int J Gynecol Pathol. 2015 Jan; 34 (1):57-64
    View PubMed
  114. Ayeni TA, AlHilli MM, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach? Int J Gynecol Cancer. 2015 Jan; 25(1):87-91.
    View PubMed
  115. Galanis E, Atherton PJ, Maurer MJ, Knutson KL, Dowdy SC, Cliby WA, Haluska P Jr, Long HJ, Oberg A, Aderca I, Block MS, Bakkum-Gamez J, Federspiel MJ, Russell SJ, Kalli KR, Keeney G, Peng KW, Hartmann LC. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Res. 2015 Jan 1; 75 (1):22-30 Epub 2014 Nov 14
    View PubMed
  116. Lessard-Anderson CR, Handlogten KS, Molitor RJ, Dowdy SC, Cliby WA, Weaver AL, Sauver JS, Bakkum-Gamez JN. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2014 Dec; 135 (3):423-7 Epub 2014 Oct 12
    View PubMed
  117. Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014 Oct; 135(1):19-24. Epub 2014 Aug 07.
    View PubMed
  118. Konecny GE, Wang C, Hamidi H, Winterhoff B, Kalli KR, Dering J, Ginther C, Chen HW, Dowdy S, Cliby W, Gostout B, Podratz KC, Keeney G, Wang HJ, Hartmann LC, Slamon DJ, Goode EL. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J Natl Cancer Inst. 2014 Oct; 106 (10) Epub 2014 Sept 30
    View PubMed
  119. AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol. 2014 Jun; 133 (3):485-93 Epub 2014 Mar 29
    View PubMed
  120. Tabbaa ZM, Janco JM, Mariani A, Dowdy SC, McGree ME, Weaver AL, Cliby WA. Short-term outcomes after incontinent conduit for gynecologic cancer: comparison of ileal, sigmoid, and transverse colon. Gynecol Oncol. 2014 Jun; 133(3):563-7. Epub 2014 Apr 02.
    View PubMed
  121. Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014 Feb; 40 (2):301-11
    View PubMed
  122. Kumar S, Podratz KC, Bakkum-Gamez JN, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Keeney GL, Thomas G, Mariani A. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol. 2014 Jan; 132 (1):38-43 Epub 2013 Oct 09
    View PubMed
  123. Mokri B, Mariani A, Heit JA, Weaver AL, McGree ME, Martin JR, Lemens MA, Cliby WA, Bakkum-Gamez JN. Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Nov; 23(9):1684-91.
    View PubMed
  124. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Mariani A. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol. 2013 Oct; 131 (1):103-8 Epub 2013 July 09
    View PubMed
  125. Uccella S, Mariani A, Wang AH, Vierkant RA, Cliby WA, Robien K, Anderson KE, Cerhan JR. Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer. Br J Cancer. 2013 Oct 1; 109(7):1908-13. Epub 2013 Sep 10.
    View PubMed
  126. Kumar S, Mariani A, Bakkum-Gamez JN, Weaver AL, McGree ME, Keeney GL, Cliby WA, Podratz KC, Dowdy SC. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol. 2013 Sep; 130 (3):441-5 Epub 2013 June 05
    View PubMed
  127. AlHilli MM, Tran CW, Langstraat CL, Martin JR, Weaver AL, McGree ME, Mariani A, Cliby WA, Bakkum-Gamez JN. Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patients. J Am Coll Surg. 2013 Sep; 217(3):507-15. Epub 2013 Jun 29.
    View PubMed
  128. Glaser G, Torres M, Kim B, Aletti G, Weaver A, Mariani A, Hartmann L, Cliby W. The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer. Gynecol Oncol. 2013 Aug; 130 (2):280-3 Epub 2013 May 11
    View PubMed
  129. Kalogera E, Bakkum-Gamez JN, Jankowski CJ, Trabuco E, Lovely JK, Dhanorker S, Grubbs PL, Weaver AL, Haas LR, Borah BJ, Bursiek AA, Walsh MT, Cliby WA, Dowdy SC. Enhanced recovery in gynecologic surgery. Obstet Gynecol. 2013 Aug; 122 (2 Pt 1):319-328
    View PubMed
  130. Kumar S, Al-Wahab Z, Sarangi S, Woelk J, Morris R, Munkarah A, Dowdy SC, Mariani A, Cliby W. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol. 2013 Jul; 130(1):207-12. Epub 2013 Apr 20.
    View PubMed
  131. Kalogera E, Dowdy SC, Mariani A, Weaver AL, Aletti G, Bakkum-Gamez JN, Cliby WA. Multiple large bowel resections: potential risk factor for anastomotic leak. Gynecol Oncol. 2013 Jul; 130 (1):213-8 Epub 2013 Apr 08
    View PubMed
  132. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, Weaver AL, McGree ME, Cliby WA, Podratz KC. Predictors and costs of surgical site infections in patients with endometrial cancer. Gynecol Oncol. 2013 Jul; 130(1):100-6. Epub 2013 Apr 02.
    View PubMed
  133. Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst. 2013 Jun 5; 105(11):823-32. Epub 2013 Mar 28.
    View PubMed
  134. Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol. 2013 Jun; 129 (3):548-53 Epub 2013 Mar 21
    View PubMed
  135. Janco JM, Markovic SN, Weaver AL, Cliby WA. Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy. Gynecol Oncol. 2013 Jun; 129 (3):533-7 Epub 2013 Feb 26
    View PubMed
  136. Giuntoli RL 2nd, Lessard-Anderson CR, Gerardi MA, Kushnir CL, Cliby WA, Metzinger DS, Gostout BS. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma. Int J Gynecol Cancer. 2013 Jun; 23(5):869-76.
    View PubMed
  137. Alvarez RD, Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR 3rd, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW. We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol. 2013 Apr; 129(1):3-4.
    View PubMed
  138. Langstraat C, Cliby WA. Considerations in the surgical management of ovarian cancer in the elderly. Curr Treat Options Oncol. 2013 Mar; 14(1):12-21.
    View PubMed
  139. Kumar S, Meuter A, Thapa P, Langstraat C, Giri S, Chien J, Rattan R, Cliby W, Shridhar V. Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer. 2013 Feb 1; 119 (3):555-62 Epub 2012 Dec 03
    View PubMed
  140. AlHilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013 Feb; 128(2):294-9. Epub 2012 Oct 17.
    View PubMed
  141. Glaser G, Torres M, Kim B, Aletti G, Weaver A, Mariani A, Hartmann L, Cliby W. The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer. Obstet Gynecol Surv. 2013; 68(9):630-2.
  142. Kumar S, Meuter A, Thapa P, Langstraat C, Giri S, Chien J, Rattan R, Cliby W, Shridhar V. Metformin intake is associated with better survival in ovarian cancer: A case-control study. Obstet Gynecol Surv. 2013; 68(4):293-4.
  143. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, Kumar S, Keeney GL, Cliby WA, Mariani A. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Obstet Gynecol Surv. 2013; 68(3):199-200.
  144. Bakkum-Gamez JN, Dowdy SC, Borah BJ, Haas LR, Mariani A, Martin JR, Weaver AL, McGree ME, Cliby WA, Podratz KC. Predictors and costs of surgical site infections in patients with endometrial cancer. Obstet Gynecol Surv. 2013; 68(8):567-8.
  145. Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Basal E, Weaver AL, Visscher DW, Cliby W, Sood AK, Bhattacharya R, Mukherjee P. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PLoS One. 2013; 8 (11):e79167 Epub 2013 Nov 13
    View PubMed
  146. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Kumar S, Weaver AL, McGree ME, Haas LR, Cliby WA, Podratz KC. Factors predictive of postoperative morbidity and cost in patients with endometrial cancer. Obstet Gynecol. 2012 Dec; 120(6):1419-27.
    View PubMed
  147. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012 Dec; 127 (3):525-31 Epub 2012 Aug 29
    View PubMed
  148. Torres ML, Weaver AL, Kumar S, Uccella S, Famuyide AO, Cliby WA, Dowdy SC, Gostout BS, Mariani A. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol. 2012 Nov; 120 (5):998-1004
    View PubMed
  149. Bakkum-Gamez JN, Chien J, Clayton AC, Halling KC, Cliby WA, Dowdy SC, Kipp BR, Famuyide A, Mariani A, Oberg AL, Wentzensen N, Sherman M, Podratz KC, Shridhar V. Development of biomarkers in endometrial cancer and its precursor lesions. J Womens Health. 2012 Oct; 21(10):1004.
  150. Tabbaa ZM, Gonzalez J, Sznurkowski JJ, Weaver AL, Mariani A, Cliby WA. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution. Gynecol Oncol. 2012 Oct; 127(1):147-52. Epub 2012 Jun 13.
    View PubMed
  151. Kalogera E, Dowdy SC, Mariani A, Aletti G, Bakkum-Gamez JN, Cliby WA. Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer. Gynecol Oncol. 2012 Sep; 126 (3):391-6 Epub 2012 May 20
    View PubMed
  152. Bakkum-Gamez JN, Langstraat CL, Martin JR, Lemens MA, Weaver AL, Allensworth S, Dowdy SC, Cliby WA, Gostout BS, Podratz KC. Incidence of and risk factors for postoperative ileus in women undergoing primary staging and debulking for epithelial ovarian carcinoma. Gynecol Oncol. 2012 Jun; 125 (3):614-20 Epub 2012 Feb 24
    View PubMed
  153. Moslemi-Kebria M, El-Nashar SA, Aletti GD, Cliby WA. Intraoperative hypothermia during cytoreductive surgery for ovarian cancer and perioperative morbidity. Obstet Gynecol. 2012 Mar; 119(3):590-6.
    View PubMed
  154. Langstraat C, Aletti GD, Cliby WA. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol. 2011 Nov; 123(2):187-91. Epub 2011 Jul 26.
    View PubMed
  155. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, Gostout BS, Stanhope CR, Wilson TO, Podratz KC. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol. 2011 Oct; 123(1):58-64. Epub 2011 Jul 13.
    View PubMed
  156. Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011 Sep; 122 (3):536-40 Epub 2011 June 01
    View PubMed
  157. Crane LM, van Oosten M, Pleijhuis RG, Motekallemi A, Dowdy SC, Cliby WA, van der Zee AG, van Dam GM. Intraoperative imaging in ovarian cancer: fact or fiction? Mol Imaging. 2011 Aug; 10(4):248-57. Epub 2011 Apr 26
    View PubMed
  158. Peasland A, Wang LZ, Rowling E, Kyle S, Chen T, Hopkins A, Cliby WA, Sarkaria J, Beale G, Edmondson RJ, Curtin NJ. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines. Br J Cancer. 2011 Jul 26; 105(3):372-81. Epub 2011 Jul 05.
    View PubMed
  159. Brewster WR, Cliby W. Summary of the 2011 Annual Meeting on Women's Cancers. Gynecol Oncol. 2011 Jul; 122(1):5-8. Epub 2011 May 04.
    View PubMed
  160. Peedicayil A, Weaver A, Li X, Carey E, Cliby W, Mariani A. Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol. 2011 Apr; 121(1):64-9. Epub 2010 Dec 22.
    View PubMed
  161. Konecny GE, Winterhoff B, Kolarova T, Qi J, Manivong K, Dering J, Yang G, Chalukya M, Wang HJ, Anderson L, Kalli KR, Finn RS, Ginther C, Jones S, Velculescu VE, Riehle D, Cliby WA, Randolph S, Koehler M, Hartmann LC, Slamon DJ. Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer. Clin Cancer Res. 2011 Mar 15; 17(6):1591-602. Epub 2011 Jan 28.
    View PubMed
  162. Gonzalez Bosquet J, Peedicayil A, Maguire J, Chien J, Rodriguez GC, Whitaker R, Petitte JN, Anderson KE, Barnes HJ, Shridhar V, Cliby WA. Comparison of gene expression patterns between avian and human ovarian cancers. Gynecol Oncol. 2011 Feb; 120(2):256-64. Epub 2010 Nov 19.
    View PubMed
  163. Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, Chi DS, Bristow RE, Cliby WA. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecol Oncol. 2011 Jan; 120(1):23-8. Epub 2010 Oct 08.
    View PubMed
  164. Carey ET, El-Nashar SA, Hopkins MR, Creedon DJ, Cliby WA, Famuyide AO. Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after global endometrial ablation. J Minim Invasive Gynecol. 2011 Jan-Feb; 18(1):96-9.
    View PubMed
  165. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7.
    View PubMed
  166. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy? Int J Gynecol Cancer. 2010 Oct; 20 (7):1125-31
    View PubMed
  167. Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, Berchuck A, Society of Gynecologic Oncologists Clinical Practice Committee. Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. Obstet Gynecol. 2010 Sep; 116 (3):733-743
    View PubMed
  168. Bristow RE, Palis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol. 2010 Sep; 118(3):262-7. Epub 2010 Jun 22.
    View PubMed
  169. Aletti GD, Nordquist D, Hartmann L, Gallenberg M, Long HJ, Cliby WA. From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer. Ann Oncol. 2010 Sep; 21 (9):1772-1778 Epub 2010 Feb 05
    View PubMed
  170. El-Nashar SA, Hopkins MR, Barnes SA, Pruthi RK, Gebhart JB, Cliby WA, Famuyide AO. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic review. Am J Obstet Gynecol. 2010 Apr; 202 (4):348.e1-7 Epub 2010 Jan 08
    View PubMed
  171. El-Nashar SA, Diehl CL, Swanson CL, Thompson RL, Cliby WA, Famuyide AO, Stanhope CR. Extended antibiotic prophylaxis for prevention of surgical-site infections in morbidly obese women who undergo combined hysterectomy and medically indicated panniculectomy: a cohort study. Am J Obstet Gynecol. 2010 Mar; 202(3):306.e1-9.
    View PubMed
  172. Gonzalez Bosquet, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010 Mar; 116(3):419-23. Epub 2009 Nov 05.
    View PubMed
  173. Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC. Inherited determinants of ovarian cancer survival. Clin Cancer Res. 2010 Feb 1; 16 (3):995-1007 Epub 2010 Jan 26
    View PubMed
  174. Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Res. 2010 Feb 1; 70 (3):875-82 Epub 2010 Jan 26
    View PubMed
  175. Heisler CA, Aletti GD, Weaver AL, Melton LJ 3rd, Cliby WA, Gebhart JB. Improving quality of care: development of a risk-adjusted perioperative morbidity model for vaginal hysterectomy. Am J Obstet Gynecol. 2010 Feb; 202 (2):137.e1-5 Epub 2009 Aug 18
    View PubMed
  176. El-Nashar SA, Hopkins MR, Creedon DJ, Cliby WA, Famuyide AO. Efficacy of bipolar radiofrequency endometrial ablation vs thermal balloon ablation for management of menorrhagia: A population-based cohort. J Minim Invasive Gynecol. 2009 Nov-Dec; 16 (6):692-9
    View PubMed
  177. Powless CA, Bakkum-Gamez JN, Aletti GD, Cliby WA. Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration. Gynecol Oncol. 2009 Oct; 115 (1):86-89 Epub 2009 July 24
    View PubMed
  178. Aletti GD, Powless C, Bakkum-Gamez J, Wilson TO, Podratz KC, Cliby WA. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy. Gynecol Oncol. 2009 Jul; 114(1):32-6. Epub 2009 Apr 09.
    View PubMed
  179. Lewis KA, Lilly KK, Reynolds EA, Sullivan WP, Kaufmann SH, Cliby WA. Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin. Mol Cancer Ther. 2009 Apr; 8(4):855-63.
    View PubMed
  180. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope RC, Wilson TO, Podratz KC, Cliby WA. Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience. J Am Coll Surg. 2009 Apr; 208 (4):614-20
    View PubMed
  181. El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol. 2009 Jan; 113 (1):97-106
    View PubMed
  182. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol. 2009 Jan; 113 (1):11-17
    View PubMed
  183. Aletti GD, Podratz KC, Moriarty JP, Cliby WA, Long KH. Aggressive and complex surgery for advanced ovarian cancer: an economic analysis. Gynecol Oncol. 2009 Jan; 112 (1):16-21 Epub 2008 Nov 22
    View PubMed
  184. Aletti GD, Podratz KC, Cliby WA, Gostout BS. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment. Gynecol Oncol. 2009 Jan; 112(1):22-7. Epub 2008 Oct 23.
    View PubMed
  185. Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy--a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol. 2008 Dec; 111 (3):418-24 Epub 2008 Oct 02
    View PubMed
  186. Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol. 2008 May; 109 (2):303-7 Epub 2008 Apr 01
    View PubMed
  187. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr; 109 (1):11-8 Epub 2008 Mar 04
    View PubMed
  188. Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, Cliby WA. Mullerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Gynecol Oncol. 2008 Jan; 108(1):141-8. Epub 2007 Nov 07.
    View PubMed
  189. Lewis KA, Bakkum-Gamez J, Loewen R, French AJ, Thibodeau SN, Cliby WA. Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers. Genes Chromosomes Cancer. 2007 Dec; 46 (12):1061-8
    View PubMed
  190. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007 Dec; 197 (6):676.e1-7
    View PubMed
  191. Dowdy SC, Mariani A, Bakkum JN, Cliby WA, Keeney GL, Podratz KC. Treatment of pulmonary recurrences in patients with endometrial cancer. Gynecol Oncol. 2007 Nov; 107(2):242-7. Epub 2007 Sep 17.
    View PubMed
  192. Thomas MB, Mariani A, Cliby WA, Keeney GL, Podratz KC, Dowdy SC. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107 (2):190-3 Epub 2007 Sept 06
    View PubMed
  193. Thomas MB, Mariani A, Cliby WA, Keeney GA, Podratz KC, Dowdy SC. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007 Nov; 107(2):186-9. Epub 2007 Aug 3.
    View PubMed
  194. Dearking AC, Aletti GD, McGree ME, Weaver AL, Sommerfield MK, Cliby WA. How relevant are ACOG and SGO guidelines for referral of adnexal mass? Obstet Gynecol. 2007 Oct; 110(4):841-8.
    View PubMed
  195. Aletti GD, Santillan A, Eisenhauer EL, Hu J, Aletti G, Podratz KC, Bristow RE, Chi DS, Cliby WA. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol Oncol. 2007 Oct; 107 (1):99-106 Epub 2007 June 28
    View PubMed
  196. Williams TI, Toups KL, Saggese DA, Kalli KR, Cliby WA, Muddiman DC. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. J Proteome Res. 2007 Aug; 6(8):2936-62. Epub 2007 Jun 21.
    View PubMed
  197. Cliby W, Aletti G. Surgical mangement of diaphragm disease in ovarian cancer. Operative Techniques in General Surgery. 2007 Jun; 9:61-8.
  198. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007 Jun; 82(6):751-70.
    View PubMed
  199. Gonzalez Bosquet J, Magrina JF, Magtibay PM, Gaffey TA, Cha SS, Jones MB, Podratz KC, Cliby WA. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gynecol Oncol. 2007 Jun; 105 (3):742-6 Epub 2007 Mar 26
    View PubMed
  200. El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, Cliby WA, Famuyide AO. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol. 2007 Jun; 109(6):1381-7.
    View PubMed
  201. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007 Apr; 105(1):84-9. Epub 2006 Dec 08.
    View PubMed
  202. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol. 2007 Feb 1; 25(4):384-9.
    View PubMed
  203. Cliby W, Aletti G. Surgical management of diaphragm disease in ovarian cancer. Operative Techniques in General Surgery. 2007; 9(2):61-9.
  204. Bosquet J, Cliby W. Vaginal Neoplasia Oncology. 2007.
  205. Aletti GD, Long HJ, Podratz KC, Cliby WA. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Gynecol Oncol. 2007 Jan; 104(1):212-6. Epub 2006 Oct 04.
    View PubMed
  206. Cliby WA, Aletti GD, Wilson TO, Podratz KC. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006 Dec; 103(3):797-801. Epub 2006 Oct 18.
    View PubMed
  207. Aletti GD, Dowdy S, Podratz KC, Cliby WA. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006 Dec; 195(6):1862-8.
    View PubMed
  208. Richardson DL, Mariani A, Cliby WA. Risk factors for anastomotic leak after recto-sigmoid resection for ovarian cancer. Gynecol Oncol. 2006 Nov; 103(2):667-72. Epub 2006 Jun 23.
    View PubMed
  209. Aletti GD, Podratz KC, Jones MB, Cliby WA. Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer. J Am Coll Surg. 2006 Oct; 203(4):521-6. Epub 2006 Aug 23.
    View PubMed
  210. Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J Clin Invest. 2006 Jul; 116 (7):1994-2004 Epub 2006 June 08
    View PubMed
  211. Gavrilova-Jordan LP, Lesnick TG, Cliby WA. Method of Removal of Ovarian Mature Cystic Teratoma and Long-Term Risk of Recurrence. Obstet and Gynecol. 2006 Jun.
  212. Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon (vol 100, pg 33, 2006). Gynecol Oncol. 2006 Jun; 101(3):553.
  213. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006 May; 101 (2):200-8 Epub 2006 Feb 28
    View PubMed
  214. Dowdy SC, Mariani A, Cliby WA, Haddock MG, Petersen IA, Sim FH, Podratz KC. Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. Gynecol Oncol. 2006 May; 101(2):280-6.
    View PubMed
  215. Mariani A, Sebo TJ, Cliby WA, Keeney GL, Riehle DL, Lesnick TG, Podratz KC. Role of bcl-2 in endometrioid corpus cancer: an experimental study. Anticancer Res. 2006 Mar-Apr; 26 (2A):823-7
    View PubMed
  216. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol. 2006 Feb; 100(2):283-7. Epub 2005 Sep 22.
    View PubMed
  217. Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006 Jan; 100 (1):33-7 Epub 2005 Sept 08
    View PubMed
  218. Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006 Jan; 107 (1):77-85
    View PubMed
  219. Karnitz LM, Flatten KS, Wagner JM, Loegering D, Hackbarth JS, Arlander SJ, Vroman BT, Thomas MB, Baek YU, Hopkins KM, Lieberman HB, Chen J, Cliby WA, Kaufmann SH. Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. Mol Pharmacol. 2005 Dec; 68 (6):1636-44 Epub 2005 Aug 26
    View PubMed
  220. Lewis KA, Mullany S, Thomas B, Chien J, Loewen R, Shridhar V, Cliby WA. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res. 2005 Aug 15; 65 (16):7091-5
    View PubMed
  221. Gonzalez Bosquet J, Magrina JF, Gaffey TA, Hernandez JL, Webb MJ, Cliby WA, Podratz KC. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol. 2005 Jun; 97 (3):828-33
    View PubMed
  222. Tebben PJ, Kalli KR, Cliby WA, Hartmann LC, Grande JP, Singh RJ, Kumar R. Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc. 2005 Jun; 80 (6):745-51
    View PubMed
  223. Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, Bast RC, Stec J, Iartchouk N, Smith DI, Ross JS, Hoersch S, Shridhar V, Lillie J, Kaufmann SH, Clark EA, Damokosh AI. Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res. 2005 Mar 15; 11(6):2149-55.
    View PubMed
  224. Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int J Cancer. 2005 Feb 20; 113(5):782-8.
    View PubMed
  225. Helt CE, Cliby WA, Keng PC, Bambara RA, O'Reilly MA. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J Biol Chem. 2005 Jan 14; 280(2):1186-92.
    View PubMed
  226. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol. 2004 Sep; 94(3):655-60.
    View PubMed
  227. Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer. 2004 Jul 15; 101 (2):346-52
    View PubMed
  228. Kalli KR, Chen BK, Bale LK, Gernand E, Overgaard MT, Oxvig C, Cliby WA, Conover CA. Pregnancy-associated plasma protein-A (PAPP-A) expression and insulin-like growth factor binding protein-4 protease activity in normal and malignant ovarian surface epithelial cells. Int J Cancer. 2004 Jul 10; 110: (5)633-40.
    View PubMed
  229. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res. 2004 Apr 15; 10(8):2681-6.
    View PubMed
  230. Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol. 2003 Dec; 91 (3):518-25
    View PubMed
  231. Giuntoli RL, Winburn KA, Silverman MB, Keeney GL, Cliby WA. Frozen section evaluation of cervical cold knife cone specimens is accurate in the diagnosis of microinvasive squamous cell carcinoma. Gynecol Oncol. 2003 Nov; 91(2):280-4.
    View PubMed
  232. Borowski K, Cliby WA. Modern Management of Postpartum Hemorrhage. Postgrad Obstet Gynecol. 2003 Nov; 23:1-8.
  233. Feitoza SS, Gebhart JB, Gostout BS, Wilson TO, Cliby WA. Efficacy of thermal balloon ablation in patients with abnormal uterine bleeding. Am J Obstet Gynecol. 2003 Aug; 189 (2):453-7
    View PubMed
  234. Magtibay PM, Friedman JA, Rao RD, Buckner JC, Cliby WA. Unusual presentation of adult metastatic peritoneal medulloblastoma associated with a ventriculoperitoneal shunt: a case study and review of the literature. Neuro Oncol. 2003 Jul; 5 (3):217-20
    View PubMed
  235. Merideth MA, Cliby WA, Keeney GL, Lesnick TG, Nagorney DM, Podratz KC. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol. 2003 Apr; 89 (1):16-21
    View PubMed
  236. Peethambaram PP, Cliby WA, Lubiniecki G, Clayton AC, Roche PC, Iturria SJ, Hartmann LC, Hellstrom I, Strome SE. Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy. Gynecol Oncol. 2003 Apr; 89 (1):99-104
    View PubMed
  237. Dowdy SC, Cliby WA. Preparing for the unexpected: encountering gynecological problems when operating for colon cancer. Curr Surg 2003 Jan-Feb; 60 (1):12-16
    View PubMed
  238. Bergen HR 3rd, Vasmatzis G, Cliby WA, Johnson KL, Oberg AL, Muddiman DC. Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry. Dis Markers. 2003-2004; 19(4-5):239-49.
    View PubMed
  239. Gaunt GA, Gostout BS, Remstein E, Cliby WA. Pelvic Castleman disease presenting as vaginal occlusion. Obstet Gynecol. 2002 Nov; 100 (5 Pt 2):1082-5
    View PubMed
  240. Carley ME, Cliby WA, Spelsberg TC. P2X(3) receptor subunit messenger RNA expression in the female mouse bladder after oophorectomy with or without estrogen replacement. Am J Obstet Gynecol. 2002 Jul; 187 (1):103-6
    View PubMed
  241. Cliby WA. Abdominal incision wound breakdown. Clin Obstet Gynecol. 2002 Jun; 45 (2):507-17
    View PubMed
  242. Gostout BS, Cliby WA, Podratz KC. Prevention and management of acute intraoperative bleeding. Clin Obstet Gynecol. 2002 Jun; 45 (2):481-91
    View PubMed
  243. Cliby WA, Lewis KA, Lilly KK, Kaufmann SH. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J Biol Chem. 2002 Jan 11; 277 (2):1599-606 Epub 2001 Nov 07
    View PubMed
  244. Cliby W, Lewis K, Lilly K, Kaufmann S. S phase and G(2) arrests induced by topoisomerase I poisons are dependent on ATR kinase function. J Biol Chem. 2002; 277(2):1599-606.
  245. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC Jr, James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 2001 Aug 1; 61(15):5895-904.
    View PubMed
  246. Connolly DC, Katabuchi H, Cliby WA, Cho KR. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome. Am J Pathol. 2000 Jan; 156(1):339-45.
    View PubMed
  247. Kawakami M, Staub J, Cliby W, Hartmann L, Cliby W, Hartmann L, Smith DI, Shridhar V. Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer. Int J Oncol. 1999 Oct; 15 (4):715-20
    View PubMed
  248. Dowdy SC, Pfeifer EA, Longcope DC, Cliby WA. Unusual recurrence of ovarian carcinoma 9 years after initial diagnosis. Gynecol Oncol. 1999 Sep; 74(3):495-8.
    View PubMed
  249. Shridhar V, Staub J, Huntley B, Cliby W, Jenkins R, Pass HI, Hartmann L, Smith DI. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene. 1999 Jul 1; 18(26):3913-8.
    View PubMed
  250. Villeneuve JB, Silverman MB, Alderete B, Cliby WA, Li H, Croghan GA, Podratz KC, Jenkins RB. Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer. Genes Chromosomes Cancer. 1999 May; 25 (1):65-9
    View PubMed
  251. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999 Jan 15; 13(2):152-7.
    View PubMed
  252. Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL, Friend SH. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO. 1998; 17:159-69.
  253. Barrette BA, Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Podratz KC, Roche PC. Overexpression of p34cdc2 protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997 Oct; 72(10):925-9.
    View PubMed
  254. Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC. Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma. Gynecol Oncol. 1997 Aug; 66(2):238-45.
    View PubMed
  255. Cliby WA. Total abdominal hysterectomy. Baillieres Clin Obstet Gynaecol. 1997 Mar; 11 (1):77-94
    View PubMed
  256. Barrette B, Srivatsa P, Cliby W, Keeney G, Suman V, Podratz K, Roche P. Over-expression of p34(cdc2) protein kinase in epithelial ovarian carcinoma. Mayo Clin Proc. 1997; 72(10):925-929.
  257. Lim PC, Tester D, Cliby W, Ziesmer SC, Roche PC, Hartmann L, Thibodeau SN, Podratz KC, Jenkins RB. Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability. Clin Cancer Res. 1996 Nov; 2: (11)1907-11.
    View PubMed
  258. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol Oncol. 1996 Mar; 60(3):363-72.
    View PubMed
  259. Dodson MK, Cliby WA, Pettavel PP, Keeney GL, Podratz KC. Female urethral adenocarcinoma: evidence for more than one tissue of origin? Gynecol Oncol. 1995 Dec; 59(3):352-7.
    View PubMed
  260. Cliby WA, Dodson MK, Podratz KC. Uterine prolapse complicated by endometrial cancer. Am J Obstet Gynecol. 1995 Jun; 172 (6):1675-80; discussion 1680-3
    View PubMed
  261. Cliby WA, Clarke-Pearson DL, Dodge R, Kohler MF, Rodriguez G, Olt GJ, Soper JT, Berchuck A, Soisson AP. Acute morbidity and mortality associated with selective pelvic and para-aortic lymphadenectomy in the surgical staging of endometrial adenocarcinoma. Journal of Gynecologic Techniques. 1995; 1(1):19-25.
  262. Hurteau JA, Rodriguez G, Berchuck A, Soper J, Cliby W, Soisson AP, Clarke-Pearson D. Closed retroperitoneal suction drainage compared to no drainage in patients having undergone selective lymphadenectomy: Risks and benefits. Journal of Gynecologic Techniques. 1995; 1:195-200.
  263. Podratz KC, Cliby WA. Second-look surgery in the management of epithelial ovarian carcinoma. Gynecol Oncol. 1994 Dec; 55(3 Pt 2):S128-33.
    View PubMed
  264. Dodson MK, Cliby WA, Keeney GL, Peterson MF, Podratz KC. Skene's gland adenocarcinoma with increased serum level of prostate-specific antigen. Gynecol Oncol. 1994 Nov; 55 (2):304-7
    View PubMed
  265. Cliby WA, Dodson MK, Podratz KC. Cervical cancer complicated by pregnancy: episiotomy site recurrences following vaginal delivery. Obstet Gynecol. 1994 Aug; 84(2):179-82.
    View PubMed
  266. Moen MD, Cliby WA, Wilson TO. Stage III papillary serous cystadenocarcinoma of the ovary in a 15-year-old female. Gynecol Oncol. 1994 May; 53(2):274-6.
    View PubMed
  267. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res. 1994 Feb 1; 54(3):610-3.
    View PubMed
  268. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 1993 Oct 1; 53(19):4456-60.
    View PubMed
  269. Cliby W, Sarkar G, Ritland SR, Hartmann LC, Podratz KC, Jenkins RB. Absence of prohibitin gene mutations in human epithelial ovarian tumors. Gynecol Oncol. 1993 Jul; 50 (1):34-7
    View PubMed
  270. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC, Jenkins RB. Human epithelial ovarian cancer allelotype. Cancer Res. 1993 May 15; 53 (10 Suppl):2393-8
    View PubMed
  271. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol. 1993 Mar; 142 (3):733-41
    View PubMed
  272. Cliby W, Soisson AP, Berchuck A, Clarke-Pearson DL. Stage I small cell cancer of the vulva treated with vulvectomy, lymphadenectomy and adjuvant chemotherapy. Cancer. 1991; 67(9):2415-7.
    View PubMed
PST-20218245